Amedisys Shares Outstanding 2010-2023 | AMED

Amedisys shares outstanding from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Amedisys Annual Shares Outstanding
(Millions of Shares)
2023 33
2022 33
2021 33
2020 33
2019 33
2018 34
2017 34
2016 34
2015 33
2014 33
2013 31
2012 30
2011 29
2010 28
2009 28
Amedisys Quarterly Shares Outstanding
(Millions of Shares)
2023-12-31 33
2023-09-30 33
2023-06-30 33
2023-03-31 33
2022-12-31 33
2022-09-30 33
2022-06-30 33
2022-03-31 33
2021-12-31 33
2021-09-30 33
2021-06-30 33
2021-03-31 33
2020-12-31 33
2020-09-30 33
2020-06-30 33
2020-03-31 33
2019-12-31 33
2019-09-30 33
2019-06-30 33
2019-03-31 33
2018-12-31 34
2018-09-30 33
2018-06-30 34
2018-03-31 35
2017-12-31 34
2017-09-30 34
2017-06-30 34
2017-03-31 34
2016-12-31 34
2016-09-30 34
2016-06-30 34
2016-03-31 34
2015-12-31 33
2015-09-30 34
2015-06-30 33
2015-03-31 33
2014-12-31 33
2014-09-30 33
2014-06-30 33
2014-03-31 32
2013-12-31 31
2013-09-30 32
2013-06-30 31
2013-03-31 31
2012-12-31 30
2012-09-30 30
2012-06-30 30
2012-03-31 30
2011-12-31 29
2011-09-30 29
2011-06-30 29
2011-03-31 29
2010-12-31 28
2010-09-30 28
2010-06-30 29
2010-03-31 28
2009-12-31 28
2009-09-30 28
2009-06-30 28
2009-03-31 27
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.978B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.733B 10.12
Quest Diagnostics (DGX) United States $15.181B 15.69
DaVita (DVA) United States $11.744B 15.98
Chemed (CHE) United States $9.320B 29.33
Encompass Health (EHC) United States $8.258B 22.65
Elanco Animal Health (ELAN) United States $6.651B 15.12
Option Care Health (OPCH) United States $5.317B 20.12
RadNet (RDNT) United States $3.344B 97.66
LifeStance Health (LFST) United States $2.326B 0.00
Astrana Health (ASTH) United States $2.077B 26.21
U.S Physical Therapy (USPH) United States $1.558B 40.39
Addus HomeCare (ADUS) United States $1.538B 23.57
Pennant (PNTG) United States $0.643B 37.58
Aveanna Healthcare Holdings (AVAH) United States $0.437B 0.00
Atai Life Sciences (ATAI) Germany $0.330B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00